Browsing: Medication & Drugs

Three large Chinese vape companies are researching nicotine-like chemicals as potential nicotine substitutes in vapes. Regulators have warned that some chemicals may be more potent and addictive than nicotine itself, and more studies are needed to understand health impacts.

Eli Lilly gains approval for their Alzheimer’s drug donanemab (Kisunla) in Japan, offering another treatment targeting amyloid plaques like Eisai’s Leqembi as the ageing population drives a rise in dementia cases.

Health Rounds: A study in mice suggested transplanting eggs from older ovaries into younger tissue could rejuvenate them and improve IVF outcomes. Researchers found a gene variant that protects some babies from jaundice by better processing bilirubin. A trial demonstrated Exelixis’ Cabometyx extended progression-free survival for patients with advanced pancreatic neuroendocrine tumours resistant to other treatments.

The weight-loss drug Ozempic is well-known for its effectiveness in managing type 2 diabetes and aiding significant weight loss. Additionally, it has recently been linked to unexpected pregnancies and new health benefits. Several women reported surprise pregnancies after using the drug. Concurrently, recent studies also suggest Ozempic could reduce the risk of kidney disease progression in diabetic patients.

Galderma, a global dermatology company, has received filing acceptances for its breakthrough treatment nemolizumab. The drug is designed to treat prurigo nodularis and moderate-to-severe atopic dermatitis in adolescents and adults. It received regulatory nods from authorities in Australia, Singapore, Switzerland, and the United Kingdom via the Access Consortium framework.

Log In or Register as a healthcare professional to read the full article.